Colin Garner
No más puestos en curso
Perfil
Colin Garner is the founder of Pharmaron Abs, Inc. which was founded in 1997.
He also held former positions as Research Director at Biocode, Inc., Non-Executive Director at Xceleron Ltd.
from 1996 to 2013, and Professor-Molecular Epidemiology at The University of York.
Antiguos cargos conocidos de Colin Garner.
| Empresas | Cargo | Fin |
|---|---|---|
Xceleron Ltd.
 Xceleron Ltd. Miscellaneous Commercial ServicesCommercial Services Xceleron Ltd. provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. It was founded in 1997 and is located in York, the United Kingdom. | Director/Miembro de la Junta | 24/01/2013 |
Pharmaron Abs, Inc.
 Pharmaron Abs, Inc. Pharmaceuticals: MajorHealth Technology Xceleron, Inc. provides drug development and biomedical research services. Its services include pharmaceutical and analytical method quality. The company was founded by Colin Garner in 1997 and is headquartered in Germantown, MD. | Fundador | - |
Biocode, Inc.
 Biocode, Inc. Office Equipment/SuppliesProducer Manufacturing Biocode identifies counterfeit solid and liquid products using a covert method based on monoclonal antibody technology. And develops techniques to provide brand protection and identification to prevent counterfeitin | Director Técnico/Científico/I+D | - |
| The University of York | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Xceleron Ltd.
Xceleron Ltd. Miscellaneous Commercial ServicesCommercial Services Xceleron Ltd. provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. It was founded in 1997 and is located in York, the United Kingdom. | Commercial Services |
Biocode, Inc.
Biocode, Inc. Office Equipment/SuppliesProducer Manufacturing Biocode identifies counterfeit solid and liquid products using a covert method based on monoclonal antibody technology. And develops techniques to provide brand protection and identification to prevent counterfeitin | Producer Manufacturing |
Pharmaron Abs, Inc.
Pharmaron Abs, Inc. Pharmaceuticals: MajorHealth Technology Xceleron, Inc. provides drug development and biomedical research services. Its services include pharmaceutical and analytical method quality. The company was founded by Colin Garner in 1997 and is headquartered in Germantown, MD. | Health Technology |
- Bolsa de valores
- Insiders
- Colin Garner
